Peter Lenting
The Prix Danièle Hermann 2009 has been awarded to Doctor Peter Lenting.
Director of Research at INSERM, Unit U770, he was awarded for his work on thrombosis and haemostatis, and moreover for his studies on two haemorrhagic syndromes, haemophilia and Willebrand’s disease. Since 1989, Doctor Lenting was working on haemostasis and thrombosis treatment. His research principally concerns three proteins, which play a major role in haemostasis: the Willebrand factor, factor VIII and factor IX.
The factor Willebrand and the factor VIII form one complex, circulating in the blood. Their deficit, just like the deficit of factor IX, is leading to a strong haemorrhagic syndrome (Willebrand’s disease, haemophilia A, haemophilia B).
← Previous newsNext news →